|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,320,000 |
Market
Cap: |
4.89(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$78.93 - $137.75 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1068 |
Guru Rank Value : 0 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Axsome Therapeutics is a biopharmaceutical company developing therapies for the management of central nervous system (CNS) conditions that have limited treatment options. Co.'s primary CNS portfolio includes: AXS-05, which is an oral, investigational N-methyl-D-aspartate receptor antagonist with multimodal activity under development for the treatment of CNS disorders; AXS-07, which is an oral, multi-mechanistic, investigational medicine under development for the acute treatment of migraine; AXS-12, which is an oral, investigational medicine in development for the treatment of narcolepsy; and AXS-14, which is an oral, investigational medicine in development for the treatment of fibromyalgia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
112,187 |
127,187 |
185,942 |
290,922 |
Total Sell Value |
$11,746,982 |
$13,698,512 |
$18,726,871 |
$26,490,613 |
Total People Sold |
3 |
4 |
5 |
6 |
Total Sell Transactions |
11 |
13 |
15 |
23 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Murdock Hunter R. |
General Counsel |
|
2025-06-23 |
4 |
AS |
$100.12 |
$602,122 |
D/D |
(6,014) |
0 |
|
2% |
|
Murdock Hunter R. |
General Counsel |
|
2025-06-23 |
4 |
OE |
$29.91 |
$179,879 |
D/D |
6,014 |
6,014 |
|
- |
|
Murdock Hunter R. |
General Counsel |
|
2025-06-20 |
4 |
AS |
$102.47 |
$768,525 |
D/D |
(7,500) |
0 |
|
3% |
|
Murdock Hunter R. |
General Counsel |
|
2025-06-20 |
4 |
OE |
$29.91 |
$224,325 |
D/D |
7,500 |
7,500 |
|
- |
|
Murdock Hunter R. |
General Counsel |
|
2025-06-18 |
4 |
AS |
$100.90 |
$756,750 |
D/D |
(7,500) |
0 |
|
0% |
|
Murdock Hunter R. |
General Counsel |
|
2025-06-18 |
4 |
OE |
$29.91 |
$224,325 |
D/D |
7,500 |
7,500 |
|
- |
|
Murdock Hunter R. |
General Counsel |
|
2025-06-17 |
4 |
AS |
$100.26 |
$751,950 |
D/D |
(7,500) |
0 |
|
2% |
|
Murdock Hunter R. |
General Counsel |
|
2025-06-17 |
4 |
OE |
$29.91 |
$224,325 |
D/D |
7,500 |
7,500 |
|
- |
|
Murdock Hunter R. |
General Counsel |
|
2025-06-16 |
4 |
AS |
$102.42 |
$768,150 |
D/D |
(7,500) |
0 |
|
2% |
|
Murdock Hunter R. |
General Counsel |
|
2025-06-16 |
4 |
OE |
$29.91 |
$224,325 |
D/D |
7,500 |
7,500 |
|
- |
|
Jacobson Mark L. |
Chief Operating Officer |
|
2025-06-09 |
4 |
AS |
$110.44 |
$2,761,000 |
D/D |
(25,000) |
5,783 |
|
-6% |
|
Jacobson Mark L. |
Chief Operating Officer |
|
2025-06-09 |
4 |
OE |
$8.02 |
$200,500 |
D/D |
25,000 |
30,783 |
|
- |
|
Coleman Mark |
|
|
2025-05-28 |
4 |
AS |
$103.43 |
$387,863 |
D/D |
(3,750) |
46,637 |
|
0% |
|
Jacobson Mark L. |
Chief Operating Officer |
|
2025-05-28 |
4 |
AS |
$103.45 |
$2,069,000 |
D/D |
(20,000) |
5,783 |
|
0% |
|
Jacobson Mark L. |
Chief Operating Officer |
|
2025-05-28 |
4 |
OE |
$6.47 |
$129,400 |
D/D |
20,000 |
25,783 |
|
- |
|
Coleman Mark |
|
|
2025-05-27 |
4 |
AS |
$105.47 |
$395,513 |
D/D |
(3,750) |
50,387 |
|
-1% |
|
Jacobson Mark L. |
Chief Operating Officer |
|
2025-05-27 |
4 |
AS |
$104.66 |
$2,163,636 |
D/D |
(20,673) |
5,783 |
|
-1% |
|
Jacobson Mark L. |
Chief Operating Officer |
|
2025-05-27 |
4 |
OE |
$6.47 |
$133,754 |
D/D |
20,673 |
26,456 |
|
- |
|
Coleman Mark |
|
|
2025-05-20 |
4 |
S |
$107.49 |
$322,473 |
D/D |
(3,000) |
54,137 |
|
5% |
|
Pizzie Nick |
Chief Financial Officer |
|
2025-02-14 |
4 |
AS |
$131.07 |
$393,210 |
D/D |
(3,000) |
42,187 |
|
-22% |
|
Pizzie Nick |
Chief Financial Officer |
|
2025-02-14 |
4 |
OE |
$3.50 |
$10,500 |
D/D |
3,000 |
45,187 |
|
- |
|
Pizzie Nick |
Chief Financial Officer |
|
2025-02-13 |
4 |
AS |
$129.86 |
$1,558,320 |
D/D |
(12,000) |
42,187 |
|
-21% |
|
Pizzie Nick |
Chief Financial Officer |
|
2025-02-13 |
4 |
OE |
$3.50 |
$42,000 |
D/D |
12,000 |
54,187 |
|
- |
|
Coleman Mark |
|
|
2025-01-03 |
4 |
OE |
$9.00 |
$82,143 |
D/D |
9,127 |
57,137 |
|
- |
|
Coleman Mark |
|
|
2024-11-19 |
4 |
OE |
$5.94 |
$198,455 |
D/D |
33,410 |
48,010 |
|
- |
|
75 Records found
|
|
Page 1 of 3 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|